|1.||De Reijke, T M: 1 article (09/2000)|
|2.||Vos, P C: 1 article (09/2000)|
|3.||de Boer, E C: 1 article (09/2000)|
|4.||Schamhart, D H: 1 article (09/2000)|
|5.||Kurth, K H: 1 article (09/2000)|
|6.||Schulman, C C: 1 article (01/2000)|
|7.||Zlotta, A R: 1 article (01/2000)|
01/01/1997 - "Urinary cytokine induction by Rubratin was comparable with cytokine induction observed in nonresponding bacillus Calmette-Guérin (BCG) patients (recurrent tumor within 6 months), but less compared with responding BCG patients (no recurrent tumor within 6 months). "
01/01/2000 - "Other immunomodulators administered intravesically investigated in clinical studies include interleukin 2 (recently used in a clinical study with a marker tumor response), levamisole, Rubratin, a Nocardia rubra cell wall skeleton, and keyhole limpet hemocyanin. "
|2.||Urinary Bladder Neoplasms (Bladder Cancer)
09/01/2000 - "Immunostimulation in the urinary bladder by local application of Nocardia rubra cell-wall skeletons (Rubratin) and bacillus Calmette-Guérin as therapy for superficial bladder cancer: a comparative study."
09/01/2000 - "Twelve patients with superficial bladder cancer were treated with intravesical instillations of Rubratin (ASTA Pharma AG, Frankfurt, Germany), a cell-wall preparation of Nocardia rubra. "
01/01/1997 - "Immunostimulation in the urinary bladder by local application of Nocardia rubra cell wall skeleton preparation (Rubratin) for superficial bladder cancer immunotherapy--a phase I/II study."
|3.||Transitional Cell Carcinoma
|1.||Cell Wall Skeleton
|4.||Immunologic Factors (Immunomodulators)
|5.||keyhole-limpet hemocyanin (keyhole limpet hemocyanin)